CHRISTINE COSGROVE: Open Payments
NPI 1568425387 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 12 payments from 6 companies in 2025. Trend: 2023 $418 · 2024 $259 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 2 | $78 |
| AstraZeneca Pharmaceuticals LP | 3 | $74 |
| BridgeBio Pharma, Inc. | 2 | $53 |
| PFIZER INC. | 2 | $51 |
| Novo Nordisk Inc | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
Products named: WAINUA, Attruby, VYNDAQEL, Wegovy, CAMZYOS.
Industry payments across CT — which companies pay providers there.
